JAN 24, 2019 10:00 AM PST

A Clinical Perspective on Sexually Transmitted Infections: What is the State of Play

Speaker
  • Sexual Health Physician - Altnagelvin Hospital, Londonderry
    Biography
      Dr. John White is a Sexual Health Physician and has been Editor-in-chief of the International Journal of STD & AIDS since 2009. After training in Sydney, Australia he worked as a clinician and researcher in the Department of Genitourinary Medicine at Guy's & St Thomas' Hospitals, London for many years until late 2017. He recently moved to Northern Ireland and now practices at the at Altnagelvin Hospital, Londonderry. Dr. White's clinical and research interests include bacterial STIs, MSM sexual health and diagnostic tests for HIV/STIs. He has a keen interest in lymphogranuloma venereum infection and is involved in several research studies involving the assessment of diagnostic tests for bacterial STIs and HIV.

    Abstract

    DATE: January 24, 2019
    TIME: 10:00am PST

    Sexually transmitted infections (STIs) continue to affect most sexually active populations across the globe, especially the traditional high-risk groups for bacterial STIs such as young people, men who have sex with men (MSM) and individuals from black and minority ethnic populations. Bacterial STIs such as Gonorrhoea and Chlamydia remain common. In western settings, we have observed the re-emergence of high rates of syphilis and lymphogranuloma venereum, mostly in MSM. Urethral and vaginal discharge syndromes, genital ulcer disease are frequent clinical presentations. However, the development of highly sensitive molecular assays has revealed that asymptomatic infections are also common, particularly at extragenital sites, and probably drive transmission of STIs. Management is best guided by the detection of organisms, but treatment is often prescribed based on observed syndromes to cover common causative organisms, before definitive diagnostic results are available or in the absence of diagnostic tests. This has become much more challenging due to increasing rates of antimicrobial resistance among some organisms, especially for Neisseria gonorrhoeae and Mycoplasma genitalium. More than ever, we rely on accurate and patient-focussed diagnostic strategies to detect and treat STIs, with partner notification being an integral component to interrupt transmission within the population.

    Learning Objectives:

    • Understand the latest epidemiological trends for the major STIs with focus on high-risk groups including MSM.
    • Be aware of recent developments in diagnostic tests for STI pathogens, particularly the advantages of molecular assays and the importance of the extragenital reservoirs.
    • Appreciate the challenges of treating bacterial STIs in an era of increasing antimicrobial resistance, especially for Neisseria gonorrhoeae and Mycoplasma genitalium.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more